Terazosin Effect on Cardiac Changes in Early Parkinson's Disease

Clinical trial NCT04386317 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04386317
Sponsor: Cedars-Sinai Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

REM Sleep Behavior Disorder Pre-motor Parkinson's Disease Symptomatic Parkinson Disease

Start date: 2020-11-01
Primary completion: 2025-12-10
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.